INTRODUCTION
There continues to be keen interest in assessing quality of life (QoL) after cystectomy and urinary diversion, given the recent evidence-based analyses [1,2] and systematic reviews [3] [4] [5] [6] evaluating QoL studies in this population. A resounding characteristic of contemporary reports is the preponderance of cross-sectional, retrospective, single-institution studies. Very few prospective longitudinal studies and no randomized controlled trials have been reported, greatly limiting the ability to draw conclusions from reported observations. Despite this limitation, most of these studies show similarly favourable overall QoL after cystectomy, irrespective of the chosen urinary diversion.
As clinicians struggle with existing reports that fail to suggest a superior type of diversion, patients continue to face the ominous task of selecting a diversion that will almost certainly affect their urinary function for the remainder of their lives. The challenge for urologists is to take the suboptimal medical reporting, objectively relay the information to patients, and facilitate integration of this information into the patient's decision-making process. Thus an understanding of this decision process is essential.
The examination of patient decision-making has gained increasing attention in the recent past. As a result, the medical community has become aware of the importance of health knowledge, communication and improved patient-physician encounters, all factors that improve patient education and permit patients to seek greater engagement in healthcare choices. Coupling accurate health information with high-quality decision counselling helps patients to understand the potential risks, benefits and uncertainties of clinical options, and assists them in selecting the option that best accommodates their personal preferences. Difficulty in interpreting information about risks can lead patients to make treatment decisions that are incompatible with their preferences, resulting in a decline in patient care and satisfaction.
Patients facing radical surgical treatment for high-risk bladder cancer have substantial fears about body image, sexuality and urinary function. These concerns not only involve potentially negative perceptions of their future health and functional well-being, but also encompass uncertainties about the practical impact of treatment and recovery on family members. These issues can greatly influence the choice of treatment and diversion, resulting in patient withdrawal from health decisions, limited treatmentseeking behaviour and potential delays in treatment delivery. For these reasons, it is imperative that urologists accurately counsel patients about the long-term experiences with various urinary diversions, to realistically set patient, spousal and family expectations in an attempt to ensure long-term satisfaction and willing adaptation.
QoL AFTER URINARY DIVERSION
Urinary tract reconstruction attempts to provide an acceptable alternative to the native bladder by creating adequate storage and continence or a reasonable conduit. Clinicians have presumed that the development of orthotopic continent diversions would replicate the normal voiding pattern and provide improved QoL over the incontinent cutaneous diversion. As a result, orthotopic diversion has globally become the most common type of urinary diversion performed after cystectomy in patients with bladder cancer (Fig. 1) . Although surgical practice patterns have changed, reflecting trends towards orthotopic diversion, a real improvement in patient QoL has been difficult to show.
Recently, a consensus conference convened by the WHO and the Société Internationale d'Urologie met to review world reports on urinary diversion [2] . No level 1 evidence was available within the reports and very few level 2 citations were found, leaving the committee to rely heavily on expert opinion and singleinstitution retrospective studies. This review, as supported by others, could not show any superiority of orthotopic diversion or continent cutaneous diversion over the ileal conduit [1-6]. Without randomized clinical trials or well-designed prospective longitudinal studies, the optimum form of urinary diversion remains unknown. Unfortunately, several major challenges make the traditional randomized trial impractical in this setting. Both patient and provider biases and expectations would greatly hamper randomization of sometimes frail patients with a multitude of comorbidities. Given the number of individual patient and family factors that enter into the choice of urinary diversion, it might be more realistic to study differences between diversion populations with a well-designed prospective study using a design founded on practice-based evidence [7] . This type of design provides comprehensive practice-based evidence for clinical practice improvement by 1 3 2 7 incorporating natural variation within data from routine clinical practice.
Despite the limitations in existing QoL studies, it is imperative that patients be informed not only about the perioperative risks and anatomical limitations of each type of urinary diversion, but also about short-and longterm outcomes, so an adequate choice of diversion can be made. Although retrospective studies suggested that patients with ileal conduit diversions have good acceptance of their stoma and overall good QoL, there remains a sense of uneasiness because of fear of urine leakage, skin problems, altered body image and sexual dysfunction, as described by both men and women [1] . Also, bowel disturbance and UTI appear to be increased over those in control populations. Early studies using primarily unvalidated instruments compared ileal conduit and continent cutaneous diversion [1] . These studies confirmed that stomal problems were more common in patients with a conduit; however, adjustment and satisfaction with current life did not differ between groups. There was substantial compromise of sexual life of the patients in both groups. Ultimately, both incontinent and continent cutaneous diversions have high perceived overall satisfaction at 1 year [8] .
More recently, the importance of using valid and reliable instruments to assess QoL has become clear, even in the retrospective, single-institution study. Various validated instruments have thus been developed and used to evaluate QoL of patients with urinary diversion (Table 1) [9] [10] [11] [12] [13] [14] . In this setting, comparisons of the ileal conduit diversion and the orthotopic neobladder still have not shown major differences in QoL, although some have reported a greater concern about urinary leakage in patients with a conduit, despite having leakage less commonly than patients with a neobladder [1] . Others suggest that patients with a conduit have a poorer body image, but overall satisfaction has been high in these patients, and notably similar to the overall satisfaction of those undergoing orthotopic diversion [1-6, 15, 16] . Only one study has suggested a clear QoL benefit in patients undergoing orthotopic diversion.
In a study of 102 (69 neobladder and 33 ileal conduit) patients, Hobish et al. [17] retrospectively examined postoperative QoL using the European Organization for the Research and Treatment of Cancer (EORTC) QoL Core Questionnaire (QLQ-C30) and an unvalidated local questionnaire. In this series, patients undergoing orthotopic diversion had significantly better adaptation, selfconfidence and rehabilitation than those with an ileal conduit. In addition, patients with a neobladder had greater restoration of leisure, professional and social activities than those undergoing ileal conduit diversion. Moreover, 97% of those with a neobladder would recommend their diversion type to a friend, compared with only 36% of those with an ileal conduit. However, the median follow-up might have contributed to differences in this cross-sectional study, with the follow-up being substantially longer in the conduit group (56 months) than in the neobladder group (28 months).
Apart from this series, most of the experience at the institutional level reflects similar QoL in patients undergoing ileal conduit, continent cutaneous and orthotopic diversions [1-6]. The lack of qualitative differences in QoL lends credibility to the theory that patients adapt to their diversion over time and have generally high satisfaction if they have accurate pretreatment expectations of the 'performance' of their diversion.
ADMINISTRATION OF QoL SURVEYS
When considering the best time to evaluate QoL after cystectomy and urinary diversion, one must consider the time required to restore psychological and health-related QoL measures back to baseline. Kulaksizoglu et al. [18] prospectively evaluated 68 patients undergoing radical cystectomy for bladder cancer. In an effort to determine the time required for these patients to adapt to their new health status, they administered the Beck Depression Inventory and the EORTC QLQ-C30 before and at 3, 6 and 12 months after surgery, and then every 6 months thereafter. The mean (range) follow-up was 28 (12-46) months. Psychological and health-related QoL measures returned to baseline values after 12 months, suggesting that either QoL improves to a baseline level at 12 months, or that it takes that long for patients to adapt to their status after cystectomy. In either case, QoL instruments are less likely to be informative when administered before this time.
In comparing QoL studies, one must also consider the confounding methods used to measure patient responses. Use of a face-toface interview, telephone interview and home survey with a disease-specific questionnaire might give differing results. Office questionnaires remain attractive to optimize response rates and minimize missing data. However, although potentially more cumbersome, it is most advantageous to engage a neutral party for interviews to optimize legitimacy [19] .
QoL INSTRUMENTS
Historically, the assessment of QoL after urinary diversion was hampered by a lack of valid and reliable tools to measure bladder cancer-related QoL, resulting only in speculation about the outcomes of diversion. In the recent past, several tools have been developed (Table 1) to measure general and cancer-specific QoL. The sensitivity of these instruments to distinguish differences in QoL between patients with conduit, orthotopic and continent cutaneous diversions remains unclear. However, several institutions have attempted to adapt earlier versions of general or cancer-specific instruments to try to improve this sensitivity, creating bladder cancer-specific instruments. The ultimate success of these instruments certainly depends on consideration of several aspects of the patient's outcome, and expectations of patients and providers, as well as attention to recurring limitations in QoL assessments and necessary remedies ( Table 2) Preliminary results from an ongoing prospective study using this cystectomyspecific instrument suggest that patients with a neobladder have a higher QoL at baseline and 1 year after cystectomy than those undergoing ileal conduit diversions. However, at 1 year, patients with a conduit have a consistent improvement in scores over their initial presentation, while those with a neobladder do not; additional studies are forthcoming.
The Bladder Cancer Index (BCI) represents the next generation of QoL assessment, developed as a reliable and valid QoL instrument for patients with bladder cancer managed with endoscopic, intravesical or radical surgical treatments [12] . The instrument was developed using standard psychometric methods; it consists of 34 items with three primary domains measuring urinary, bowel, and sexual health, and two subdomains, function and bother. Recently the BCI was administered retrospectively to a group of 315 patients with bladder cancer; 127 with a native bladder, 66 treated with cystectomy and ileal conduit diversion, and 122 with cystectomy and neobladder diversion. Patients with native bladders uniformly had higher adjusted urinary, bowel and sexual function domain scores than those undergoing orthotopic diversion (Table 3 ) [12] . Patients undergoing ileal conduit and orthotopic diversion had similar adjusted bowel and sexual function scores. Patients with ileal conduit diversion had significantly higher functional urinary domain scores than those with orthotopic diversion, yet the bother in both groups was similar. Overall, the BCI showed functional and bother differences in patients with bladder cancer treated with various approaches. Longitudinal studies are forthcoming.
SURVIVORSHIP IN PATIENTS WITH BLADDER CANCER
In the 1940s and 50s, when radical cystectomy was being popularized by Marshall and Whitmore [20] , the concept of cancer therapy encompassed large operations with multi-organ resection. Over the past 10-20 years the preservation of organ function coupled with local cancer control has become a major objective of urological oncologists. The logical extension of this conceptual practice is the restoration of QoL after cancer surgery. Previously, postoperative adjustment to changes in body image, sexual function, urinary function and self-esteem were unevaluated, and to some degree, ignored. Continued improvements in urinary diversion must consider health-related QoL and other aspects of long-term survivorship that have become increasingly important.
More recently, survivorship clinics have been established to facilitate psychosocial rehabilitation. Multidisciplinary teams consisting of nursing professionals, sex therapists, social workers, and urological oncologists collaborate on methods to reduce patient stress, diminish fear, improve sexual and urinary function, and regain a sense of well-being. Such clinics are models for potential psychosocial interventions that can assist in the psychosocial recovery of patients undergoing urinary diversion.
Some remain sceptical about the impact of psychosocial interventions in the urinary diversion population, although there might be a benefit for selected patients. Mansson et al. [21] randomized 50 patients with a diversion (17 ileal conduit, 17 continent cutaneous, and 16 neobladders) to undergo a psychosocial intervention, comprising weekly counselling 4-9 weeks after surgery. All patients were evaluated with the Sickness-Impact Profile (SIP) and the meta-contrast technique (MCT), an analysis used to reflect individual defensive strategies at the subconscious or unconscious level. The patient's general philosophical outlook was recorded before and after surgery. They found no significant difference in the results of the SIP between the intervention and the no-intervention groups. In a subset analysis, the intervention appeared to benefit patients with continent cutaneous diversion, who had significantly lower psychosocial scores than those with a conduit or neobladder. Analyses from the MCT did not distinguish the intervention from the no-intervention group. Despite little overall impact of these generalized interventions, it might be that interventions tailored to specific patients with bladder cancer will facilitate aspects of QoL recovery.
CARE AFTER SURGERY
Like other cancer survivors, patients with bladder cancer also have concerns about receiving adequate follow-up care. To address these growing concerns, the Institute of Besides the physical and psychosocial sequelae of bladder cancer, patients must understand their ongoing needs for follow-up care. Survivorship care-plans represent one approach to documenting previous cancer treatments and needs for future care [23] . Although such care plans are not yet in wide use, they hold promise as a way of assembling a patient's previous cancer-related treatments, their history of comorbid conditions, and other relevant medical information so that it can be accessible to both the patient and future healthcare providers. The plan might document both the need for late toxicity monitoring, and the surveillance needed for cancer recurrence or for a second primary cancer. The IOM recommends that care plans clearly identify providers responsible for survivorship care, encourage disease-preventive actions patients should take and document patients' needs for psychosocial or vocational assistance [23] .
To date, research on health-related QoL for patients with bladder cancer has been limited, few patient education interventions exist, and funding for such research or intervention development has been marginal. Because some symptom concerns mentioned above are similar to those of patients with cancers at other sites (e.g. men after radical prostatectomy have erectile difficulties similar to those experienced by men after cystectomy), it might be possible to adapt patient-education materials about other cancers for those with bladder cancer. As individual institutions explore survivorship strategies, it will be important to embark on collaborative plans to develop and assess interventions in a prospective and longitudinal fashion.
INTERVENTIONS FOR DECISION-MAKING
The development of patient-centred decision aids for urinary diversion will be a central component in the next phase of improved bladder cancer care. A key understanding of general principles in decision-making and in creating decision tools is necessary to establish a conceptual framework for this endeavour. As with any new patient-education intervention, patient decision aids for those with bladder cancer need to be evaluated to ensure that they are providing accurate information that is being correctly understood by the target audience. In addition, decision aids need to be reevaluated and revised as new treatment options or other information relevant to patient decision-making becomes available [35] .
CONCLUSION
QoL after continent diversion has not been confirmed to be better than after incontinent diversion; this observation makes the choice of urinary diversion a difficult and challenging one for the patient and clinician. The development of patient decision tools might help to improve the process of selecting appropriate bladder cancer treatments, including the choice of urinary diversion, for individual patients. There are many reported in prostate cancer on which to draw upon to begin to understand the needs of cancer survivors and ways to study the specific needs of bladder cancer patients and survivors. Urologists, outcomes researchers and patient educators all have important roles in helping patients make decisions that: (i) take into account patient preferences and values; (ii) are based on clearly presented information about treatment options, clinical outcomes and survivorship concerns; and (iii) involve healthcare providers in a conversation that can lead to shared decision-making. Patients need our help in understanding how to live with the physical and psychosocial burden of their cancer diagnosis and treatment-related side-effects. To further our understanding, we will also have the challenge of working with policy makers and funders to ensure that more money is available to support the development of patient-centred programmes in this understudied area of cancer decision-making and survivorship.
